BIO 2019 - June 3-6 - Philadelphia, PA


GLORIA Team, National Yang-Ming University Shines at 2019 BIO International Convention, Philadelphia


BIO International Convention 2019, the world’s largest annual biotechnology industrial event, had a great start in Philadelphia, East Coast of the United States. Under the leadership of Chief Executive officer Hsien-Chih Pei of the Global research & industry alliance (GLORIA), National Yang-Ming University, Director Ueng-Cheng Yang’s team of the Center for Systems and Synthetic Biology and Prof. Tse-Ying Liu’s team of the Department of BioMedical Engineering have yielded fruitful research and development (R&D) results during the event. The hard work has paid off, as their products have successfully attracted a considerable number of domestic and international firms to discuss with them about collaboration.

Deputy Director General Chun-Yi Tu of the Ministry of Science and Technology and Chief Executive Officer Hsien-Chih Pei of the Global research & industry alliance (GLORIA), National Yang-Ming University witnessed the historical scene of Director Ueng-Cheng Yang of the Center for Systems and Synthetic Biology (the first person on the right) signing a contract with L7 Informatics (the first person on the left).


Five of National Yang-Ming University’s significant R&D products have shone at this year’s BIO International Convention. Prof. Tse-Ying Liu has developed a new model of radiotherapy platform for cancer treatment, namely Targeted Sensitization Enhanced Radiotherapy (TSER), which shows specificity and lowers the radiation dosage required for radiotherapy. Director Ueng-Cheng Yang has developed a Clinical Informatics & Management System (CIMS,) which dramatically improves the quality and efficiency of clinical trials, and enhances the management of clinical trial data. Prof. Feng-Yi Yang’s transcranial ultrasound technology can be applied to the treatment of dementia/Alzheimer’s Disease. Prof. Shih-Hwa Chiou’s peptide specifically inhibits the progression of brain tumors. Prof. Yu-Te Wu, Dean of Research and Development, has established an assistive automatic lesion detection, tracking, and precision medicine model for acoustic neuroma.

Among the products, Director Ueng-Cheng Yang’s Clinical Informatics & Management System had been favored by L7 Informatics at last year’s BIO International Convention, Boston, and the two parties signed a Memorandum of Understanding in Taiwan after the event. With the assistance of GLORIA, National Yang-Ming University, the two parties’ one-year efforts have finally borne fruit at this year’s BIO International Convention, Philadelphia. Chief Executive Officer Vasu Rangadass of L7 Informatics has specially traveled to Philadelphia to sign the official contract with Director Ueng-Cheng Yang. Everybody is looking forward to their follow-up product development after the collaboration.


A photograph was taken in front of the vendor for the visiting members of the Academia and Industry Collaboration from the 12 universities of the Ministry of Science and Technology.



During the BIO International Convention event, Tsung-Tsong Wu, Minister without Portfolio, has led the team representing Taiwan to visit the Pennovation Center, an internationally renowned startup incubator. They learned on-site how startup accelerators overseas operate. The universities representing the Taiwan team, namely the GLORIA team, were National Yang-Ming University, National Sun Yat-sen University, and National Taiwan Ocean University. They brought the experiences gained separately back to Taiwan and shared with the Center for Academia and Industry Collaboration of each university.

Besides, the Re-defining Early-Stage Investment Conference (RESI Conference) is a global investment matching meeting established for biotech startup companies. The goal is to match startup enterprises and global investors to raise funds and develop collaborative relationships. GLORIA, National Yang-Ming University, recommended Prof. Tse-Ying Liu’s team, a promising team among the startup teams, to attend RESI, looking for collaboration opportunities through communication with global investors.